Диссертация (1145920), страница 22
Текст из файла (страница 22)
//J. Neurochem. 1986. V. 46. (6). P. 1820–34.228. Selkoe D.J., Ihara Y., Salazar F.J. Alzheimer’s disease: insolubility of partiallypurified paired helical filaments in sodium dodecyl sulfate and urea. // Science.1982. V. 215. (4537). P. 1243–5.229. Serio T.R., Cashikar A.G., Moslehi J.J., Kowal A.S., Lindquist S.L. Yeast prion[psi +] and its determinant, Sup35p. // Methods Enzymol. 1999. V. 309. P.
649–73.230. Sherman F., Fink G.R., Hancks J.B. Methods in yeast genetics. New York:N.Y.Cold Spring Harbor Lab. Press., 1986. 367 p.131231. Shewmaker F., Ross E.D., Tycko R., Wickner R.B. Amyloids of Shuffled PrionDomains That Form Prions Have a Parallel In-Register β-Sheet Structure†//Biochemistry.
2008. V. 47. (13). P. 4000–4007.232. Shirahama T., Cohen A.S. High-resolution electron microscopic analysis of theamyloid fibril. // J. Cell Biol. 1967. V. 33. (3). P. 679–708.233. Si K., Giustetto M., Etkin A., Hsu R., Janisiewicz A.M., Miniaci M.C., Kim J.H., Zhu H., Kandel E.R. A neuronal isoform of CPEB regulates local proteinsynthesis and stabilizes synapse-specific long-term facilitation in aplysia. // Cell.2003.
V. 115. (7). P. 893–904.234. Sieben A., Langenhove T. Van, Engelborghs S., Martin J.-J., Boon P., Cras P.,Deyn P.-P. De, Santens P., Broeckhoven C. Van, Cruts M. The genetics andneuropathology of frontotemporal lobar degeneration // Acta Neuropathol. 2012.V. 124. (3). P. 353–372.235. Sikorski R.S., Hieter P. A system of shuttle vectors and yeast host strainsdesigned for efficient manipulation of DNA in Saccharomyces cerevisiae.
//Genetics. 1989. V. 122. (1). P. 19–27.236. Sipe J.D., Benson M.D., Buxbaum J.N., Ikeda S., Merlini G., Saraiva M.J.M.,Westermark P. Nomenclature 2014: Amyloid fibril proteins and clinicalclassification of the amyloidosis // Amyloid. 2014. V. 21. (4). P. 221–224.237. Sipe J.D., Cohen A.S. Review: History of the Amyloid Fibril // J. Struct. Biol.2000. V. 130. (2–3).
P. 88–98.238. Sironi L., Mapelli M., Knapp S., Antoni A. De, Jeang K.-T., Musacchio A.Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a«safety belt» binding mechanism for the spindle checkpoint. // EMBO J. 2002. V.21. (10). P. 2496–506.239. Skinner M., Cohen A.S. The prealbumin nature of the amyloid protein infamilial amyloid polyneuropathy (FAP)-swedish variety. // Biochem. Biophys.Res. Commun. 1981. V. 99. (4). P. 1326–32.240.
Sondheimer N., Lindquist S. Rnq1: an epigenetic modifier of protein functionin yeast. // Mol. Cell. 2000. V. 5. (1). P. 163–72.132241. Sorenson J.R. Prion diseases: copper deficiency states associated with impairednitrogen monoxide or carbon monoxide transduction and translocation. // J. Inorg.Biochem. 2001. V. 87. (3). P.
125–7.242. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B.Mutation in the tau gene in familial multiple system tauopathy with preseniledementia. // Proc. Natl. Acad. Sci. U. S. A. 1998. V. 95. (13). P. 7737–41.243. Stansfield I., Jones K.M., Kushnirov V. V, Dagkesamanskaya A.R.,Poznyakovski A.I., Paushkin S. V, Nierras C.R., Cox B.S., Ter-Avanesyan M.D.,Tuite M.F. The products of the SUP45 (eRF1) and SUP35 genes interact tomediate translation termination in Saccharomyces cerevisiae. // EMBO J.
1995.V. 14. (17). P. 4365–73.244. Steensma D.P. «Congo» red: out of Africa? // Arch. Pathol. Lab. Med. 2001.V. 125. (2). P. 250–2.245. Sunde M., Blake C.C. From the globular to the fibrous state: protein structureand structural conversion in amyloid formation. // Q. Rev. Biophys.
1998. V. 31.(1). P. 1–39.246. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C..Common core structure of amyloid fibrils by synchrotron X-ray diffraction // J.Mol. Biol. 1997. V. 273. (3). P. 729–739.247. Tanaka M., Weissman J.S. An efficient protein transformation protocol forintroducing prions into yeast. // Methods Enzymol. 2006. V. 412.
P. 185–200.248. Tartaglia G.G., Cavalli A., Pellarin R., Caflisch A. The role of aromaticity,exposed surface, and dipole moment in determining protein aggregation rates //Protein Sci. 2004. V. 13. (7). P. 1939–1941.249. Tartaglia G.G., Pechmann S., Dobson C.M., Vendruscolo M. Life on the edge:a link between gene expression levels and aggregation rates of human proteins //Trends Biochem. Sci. 2007. V. 32. (5). P. 204–206.250. Tartaglia G.G., Vendruscolo M. The Zyggregator method for predicting proteinaggregation propensities // Chem.
Soc. Rev. 2008. V. 37. (7). P. 1395.133251. Tartaglia G.G., Vendruscolo M. Correlation between mRNA expression levelsand protein aggregation propensities in subcellular localisations // Mol. Biosyst.2009. V. 5. (12). P. 1873.252. Ter-Avanesyan M.D., Dagkesamanskaya A.R., Kushnirov V. V., Smirnov V.N.The SUP35 omnipotent suppressor gene is involved in the maintenance of thenon-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae //Genetics. 1994. V. 137. (3). P. 671–676.253. Ter-Avanesyan M.D., Kushnirov V.
V, Dagkesamanskaya a R., Didichenko S.a, Chernoff Y.O., Inge-Vechtomov S.G., Smirnov V.N. Deletion analysis of theSUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlappingfunctional regions in the encoded protein. // Mol. Microbiol. 1993.
V. 7. (5). P.683–692.254. Toombs J.A., Liss N.M., Cobble K.R., Ben-Musa Z., Ross E.D. [PSI+]maintenance is dependent on the composition, not primary sequence, of theoligopeptide repeat domain. // PLoS One. 2011. V. 6. (7). P. e21953.255. Toombs J.A., McCarty B.R., Ross E.D. Compositional determinants of prionformation in yeast. // Mol. Cell. Biol.
2010. V. 30. (1). P. 319–32.256. Toombs J.A., Petri M., Paul K.R., Kan G.Y., Ben-Hur A., Ross E.D. De novodesign of synthetic prion domains. // Proc. Natl. Acad. Sci. U. S. A. 2012. V. 109.(17). P. 6519–24.257. Traczyk A., Biliński T., Litwińska J., Skoneczny M., Rytka J. Catalase Tdeficient mutants of Saccharomyces cerevisiae. // Acta Microbiol. Pol. 1985. V.34. (3–4).
P. 231–41.258. Trovato A., Seno F., Tosatto S.C.E. The PASTA server for protein aggregationprediction // Protein Eng. Des. Sel. 2007. V. 20. (10). P. 521–523.259. Tsigelny I.F., Crews L., Desplats P., Shaked G.M., Sharikov Y., Mizuno H.,Spencer B., Rockenstein E., Trejo M., Platoshyn O., Yuan J.X.-J., Masliah E.Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of CombinedAlzheimer’s and Parkinson’s Diseases // PLoS One. 2008.
V. 3. (9). P. e3135.134260. Tsolis A.C., Papandreou N.C., Iconomidou V.A., Hamodrakas S.J. AConsensus Method for the Prediction of ‘Aggregation-Prone’ Peptides inGlobular Proteins // PLoS One. 2013. V. 8. (1). P. e54175.261. Tuite M.F., Mundy C.R., Cox B.S. Agents that cause a high frequency ofgenetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. // Genetics.1981. V. 98. (4). P. 691–711.262. Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., Carvalho M. de,Ince P.G., Lin C., Miller R.G., Mitsumoto H., Nicholson G., Ravits J., Shaw P.J.,Swash M., Talbot K., Traynor B.J., Berg L.H. Van den, Veldink J.H., Vucic S.,Kiernan M.C. Controversies and priorities in amyotrophic lateral sclerosis //Lancet Neurol.
2013. V. 12. (3). P. 310–322.263. Tycko R., Wickner R.B. Molecular Structures of Amyloid and Prion Fibrils:Consensus versus Controversy // Acc. Chem. Res. 2013. V. 46. (7). P. 1487–1496.264. Urakov V.N., Valouev I. a, Kochneva-Pervukhova N. V, Packeiser A.N.,Vishnevsky A.Y., Glebov O.O., Smirnov V.N., Ter-Avanesyan M.D. N-terminalregion of Saccharomyces cerevisiae eRF3 is essential for the functioning of theeRF1/eRF3 complex beyond translation termination. // BMC Mol. Biol. 2006. V.7.
P. 34.265. Uversky V.N., Fink A.L. Conformational constraints for amyloid fibrillation:the importance of being unfolded // Biochim. Biophys. Acta - ProteinsProteomics. 2004. V. 1698. (2). P. 131–153.266. Vassar P.S., Culling C.F. Fluorescent stains, with special reference to amyloidand connective tissues. // Arch. Pathol. 1959. V. 68.
P. 487–98.267. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S.J., Smart E.J., AndersonR.G., Taraboulos A., Prusiner S.B. Subcellular colocalization of the cellular andscrapie prion proteins in caveolae-like membranous domains. // Proc. Natl. Acad.Sci. U. S. A. 1996. V. 93. (25). P. 14945–9.268. Wang Y., Meriin A.B., Zaarur N., Romanova N. V, Chernoff Y.O., CostelloC.E., Sherman M.Y. Abnormal proteins can form aggresome in yeast: aggresome135targeting signals and components of the machinery.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
